Advertisement
Screener

Super League Enterprise, Inc. (SLE) Spending and interest coverage

Super League Enterprise, Inc. (SLE) Spending and interest coverage

  • R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months(m)Research and development expense / revenue. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Stock-based compensation / revenue · 12 months(m)Share-based compensation / revenue. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending3.17M USDResearch and Development Expense
Revenue(m)
Stock-based compensation3.62M USDShare-based Payment Arrangement, Noncash Expense
Operating income-14.08M USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30$3.17M(m)$3.62M$-14.08M(m)(m)(m)(m)(m)
2026-03-31$2.65M(m)$3.14M$-13.58M(m)(m)(m)(m)(m)
2025-12-31$2.91M(m)$2.31M$-13.05M(m)(m)(m)(m)(m)
2025-09-30$3.33M(m)$1.68M$-14.43M(m)(m)(m)(m)(m)
2025-06-30$3.58M(m)$1.42M$-14.83M(m)(m)(m)(m)(m)
2025-03-31$3.68M(m)$1.24M$-15.78M(m)(m)(m)(m)(m)
2024-12-31$4.45M(m)$1.29M$-16.75M(m)(m)(m)(m)(m)
2024-09-30$5.64M(m)$1.55M$-25.09M(m)(m)(m)(m)(m)
2024-06-30$6.79M(m)$1.83M$-26.13M(m)(m)(m)(m)(m)
2024-03-31$8.24M(m)$2.28M$-30.22M$28.00K(m)(m)-1079.36×Reported
2023-12-31$9.50M(m)$2.73M$-32.84M$50.00K(m)(m)-656.74×Reported
2023-09-30$10.54M(m)$3.15M$-36.08M$229.00K(m)(m)-157.54×Reported
2023-06-30$12.30M(m)$3.70M$-83.66M$743.00K(m)(m)-112.60×Reported
2023-03-31$14.62M(m)$3.95M$-84.22M$717.00K(m)(m)-117.46×Reported
2022-12-31$15.88M(m)$4.26M$-84.96M$679.00K(m)(m)-125.13×Reported
2022-09-30$16.49M(m)$4.06M$-75.95M(m)(m)(m)(m)(m)
2022-06-30$15.78M(m)$3.51M$-30.84M(m)(m)(m)(m)(m)
2022-03-31$13.27M(m)$3.07M$-28.41M$4.00K(m)(m)-7103.75×Reported
2021-12-31$11.10M(m)$2.38M$-25.08M$5.00K(m)(m)-5016.00×Reported
2021-09-30$8.75M(m)$2.04M$-22.65M$8.00K(m)(m)-2831.38×Reported
2021-06-30$7.16M$3.37M$1.88M$-19.98M$11.00K212.44%55.71%-1815.91×Reported
2021-03-31$6.30M$2.61M$1.71M$-18.22M$11.00K241.51%65.66%-1656.45×Reported
2020-12-31$6.65M$2.06M$2.00M$-18.74M$8.00K322.04%97.09%-2342.88×Reported
2020-09-30$5.86M$1.55M$2.52M$-18.71M$9.76M378.60%162.96%-1.92×Reported
2020-06-30$5.66M$1.18M$2.79M$-18.84M$9.75M479.81%236.39%-1.93×Reported
2020-03-31$5.27M$1.08M$4.19M$-19.78M$9.75M488.87%388.59%-2.03×Reported
2019-12-31$4.52M$1.08M$6.22M$-20.77M$9.94M416.97%573.52%-2.09×Reported
2019-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-12-31$4.18M$1.05M$3.94M$-16.16M$4.47M399.90%376.86%-3.62×Reported
2018-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Healthcare Triangle, Inc. (HCTI)United States$0.011B
Algorhythm Holdings, Inc. (RIME)United States$0.003B-0.61
Fusemachines Inc. (FUSE)United States$0.017B
CREATIVE REALITIES, INC. (CREX)United States$0.036B-2.64
STEM, INC. (STEM)United States$0.038B-1.03
Brand Engagement Network Inc. (BNAI)United States$0.048B
Odysight.ai Inc. (ODYS)$0.054B-3.84
CSP INC /MA/ (CSPI)United States$0.077B-117.69
CID Holdco, Inc. (DAIC)United States$0.103B
WIDEPOINT CORP (WYY)United States$0.109B-137.61